SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ablynx and Algeta Enter Into a Research Collaboration to Evaluate the Potential of Novel Alpha-Pharmaceuticals Comprising Thorium-277 Conjugated to Tumour-Targeting Nanobodies